Select Cognition Coverage and Published Editorials
BIO CEO 2025: Cognition CEO debates policy while advancing CT-1812
BioWorld
By Karen Carey
February 12, 2025
Cognition Therapeutics Presents Phase 2 Results For Drug To Fight DLB At International Conference
Benzinga
By Meg Flippin
February 5, 2025
Cognition Therapeutics is Targeting a Critical Form of Dementia
Benzinga All-Access
Host: Dan Leach
January 7, 2025
Oral Small Molecule Shows Promise in Dementia with Lewy Bodies
Healio
December 23, 2024
CT1812 Meets Primary End Point in Phase 2 SHIMMER Study for Dementia with Lewy Bodies
Neurology Live
By Isabella Ciccone, MPH
December 21, 2024
Topline Results Are In: Cognition Therapeutics’ Drug To Fight Dementia With Lewy Bodies Shows Encouraging Results In Phase 2 Trial
Benzinga
By Meg Flippin
December 19, 2024
Connect with us on Social Media

